Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
risankizumab
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
risankizumab
Unique ID
C000601773
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000601773
Entry Term(s)
ABBV-066
BI 655066
BI-655066
risankizumab-rzaa
skyrizi
Registry Numbers
90ZX3Q3FR7
Heading Mapped to
*Antibodies, Monoclonal
Frequency
154
Note
a fully human IgG1 mAb selective for IL-23A; for treatment of moderate-to-severe psoriasis
Source
J Allergy Clin Immunol. 2015 Jul;136(1); 116-124.e7
Indexing Information
Interleukin-23 Subunit p19
Date of Entry
2015/10/02
Revision Date
2021/01/28
Expand All
Collapse All
risankizumab
Preferred
Concept UI
M000631319
Registry Numbers
90ZX3Q3FR7
Terms
risankizumab
Preferred Term
Term UI
T000923763
Date
05/09/2017
LexicalTag
NON
ThesaurusID
NLM (2017)
BI 655066
Narrower
Concept UI
M000610540
Terms
BI 655066
Preferred Term
Term UI
T000887485
Date
10/02/2015
LexicalTag
LAB
ThesaurusID
NLM (2015)
BI-655066
Term UI
T000966942
Date
08/28/2019
LexicalTag
NON
ThesaurusID
NLM (2019)
skyrizi
Narrower
Concept UI
M000653637
Terms
skyrizi
Preferred Term
Term UI
T000964566
Date
08/06/2019
LexicalTag
TRD
ThesaurusID
NLM (2019)
risankizumab-rzaa
Term UI
T000966943
Date
08/28/2019
LexicalTag
NON
ThesaurusID
NLM (2019)
ABBV-066
Related
Concept UI
M000654895
Terms
ABBV-066
Preferred Term
Term UI
T000966944
Date
08/28/2019
LexicalTag
LAB
ThesaurusID
NLM (2019)
page delivered in 0.003s